| Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
|---|
| 09/21/2005 | CN1671420A Pegylated factor VII glycoforms |
| 09/15/2005 | WO2005000404A3 Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss |
| 09/14/2005 | EP1572220A1 Antiviral, anti-infectious and cicatrising properties of extracts of dichrostachys glomerata |
| 09/14/2005 | CN1218725C Medicament compsn. for curing acute pharyngitis and its preparation method |
| 09/13/2005 | US6942853 Latent fusion protein |
| 09/09/2005 | WO2005009539A3 Compounds for inflammation and immune-related uses |
| 09/08/2005 | US20050197349 Pyrrolo[2,3-D]pyrimidine compounds |
| 09/08/2005 | US20050197299 Peptidomimetic protease inhibitors |
| 09/07/2005 | EP1438291B1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 09/07/2005 | CN1665809A Azaindoles |
| 08/31/2005 | EP1390366B1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene |
| 08/31/2005 | CN1662498A Novel tetrahydropyridine derivatives as renin inhibitors |
| 08/31/2005 | CN1662497A Derivative of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics |
| 08/31/2005 | CN1660779A Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
| 08/24/2005 | EP1504019B1 Platinum complexes having antitumor activity |
| 08/24/2005 | EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
| 08/24/2005 | EP1286975B1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists |
| 08/24/2005 | EP1131301B1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 08/24/2005 | CN1659151A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 08/24/2005 | CN1659137A N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use |
| 08/24/2005 | CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/18/2005 | US20050182112 3-[4-(3,6-dihydro-2H-thiopyran-4-yl) phenyl]-]5[1H or 2H-1,2,3-triazol-1 or 2-yl] oxazolidin-2-ones; grampositive bactericides for drug resistant bacteria, especially Staphylococcus, Enterococcus, and Streptococcus |
| 08/18/2005 | US20050182098 Administering taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions for inhibiting tumor growth |
| 08/17/2005 | EP1564210A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
| 08/17/2005 | CN1656075A Quinoline derivatives and their use as 5-HT6 ligands |
| 08/11/2005 | US20050176964 Nicotinamide derivatives useful as p38 inhibitors |
| 08/10/2005 | CN1653082A Platinum complexes having antitumor activity |
| 08/10/2005 | CN1653064A Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| 08/10/2005 | CN1652788A Method of treating diabetes |
| 08/10/2005 | CN1214029C 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroi-soquinol-2-yl)-5-(2-pyridyl) quinazo line mesylat and polymorphs |
| 08/09/2005 | US6926694 Apparatus and method for delivery of therapeutic and/or diagnostic agents |
| 08/04/2005 | US20050171118 Central nervous system, gastrointestinal and psycological disorders; such as 3-(4-chlorobenzenesulfonyl)-2-methyl-7-piperazin-1-yl-1H-indole; synthesis |
| 08/04/2005 | US20050171061 Phenylsulfanylphenyl and phenyloxyphenyl substituted piperazine compounds; glycine transport inhibitors; for the treatment of psychoses and convulsive disorders: epilepsy, spasticity, and myoclonus |
| 08/04/2005 | US20050170440 Treatment and diagnosis of insulin-resistant states |
| 08/03/2005 | EP1559717A2 Oxabispidine compounds useful in the treatment of cardiac arrythmias |
| 08/03/2005 | CN1213020C Phenylalaninol derivatives |
| 07/28/2005 | US20050165051 Taxanes having a C7 carbonate substituent |
| 07/28/2005 | US20050165022 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 07/28/2005 | US20050163744 Novel method for down-regulation of amyloid |
| 07/27/2005 | EP1556062A2 Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity |
| 07/27/2005 | EP1556015A1 Extended, controlled release pharmaceutical compositions comprising charged polymers |
| 07/27/2005 | EP1309555B1 Process for making amlodipine maleate |
| 07/27/2005 | CN1646528A Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 07/27/2005 | CN1646133A Pharmaceutical combinations of cox-2 inhibitors and opiates |
| 07/27/2005 | CN1644693A Protein having tpo activity |
| 07/21/2005 | US20050159450 Derivative of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics |
| 07/20/2005 | EP1303514B1 Process for preparing azacycloalkanoylaminothiazoles |
| 07/20/2005 | CN1640877A Novel spiro compounds |
| 07/20/2005 | CN1211365C Novel salt of perindopril and pharmacetuical composition contg. same |
| 07/13/2005 | EP1551432A1 Argyrolobium roseum plant extracts for treating diabetes |
| 07/13/2005 | EP1427711B1 Oxazolidinone and/or isoxazoline derivatives as antibacterial agents |
| 07/13/2005 | CN1639136A Oxazolidinone and/or isoxazoline as antibacterial agents |
| 07/13/2005 | CN1639115A Semicarbazide derivatives and their use as antithrombotics |
| 07/13/2005 | CN1636991A Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 07/13/2005 | CN1210279C Thiazolo (4,5-D) pyrimidine compounds |
| 07/12/2005 | US6916961 Compound for use in the prevention and treatment of respiratory and nervous system disorders |
| 07/12/2005 | CA2298142C Soya extract, process for its preparation and pharmaceutical composition |
| 07/07/2005 | WO2005009954A3 Method for modulating calcium ion-release-activated calcium ion channels |
| 07/07/2005 | US20050148633 Method for modulating calcium ion-release-activated calcium ion channels |
| 07/07/2005 | US20050148591 Tartrate salts of 5,8,14-triazatetracyclo [10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaen and pharmaceutical compositions thereof |
| 07/06/2005 | EP1140145B1 Novel exendin agonist formulations and methods of administration thereof |
| 07/06/2005 | CN1635892A Ziprasidone composition and synthetic controls |
| 07/05/2005 | CA2253545C Phosphatidic acid-comprising compositions |
| 06/30/2005 | US20050143446 Compounds for use as antigrowth agents or antitumor agents and with solvents |
| 06/29/2005 | CN1633416A Nicotinamide derivates useful as p38 inhibitors |
| 06/29/2005 | CN1208056C Medicine containing Anemonin as effective component for treating aseptic inflammation |
| 06/28/2005 | US6911217 Controlled release bead, a method of producing the same and multiple unit formulation comprising it |
| 06/22/2005 | EP1360187B1 3,7-diazabicyclo(3.3.0)octanes and their use in the treatment of cardiac arrhythmias |
| 06/22/2005 | EP1272200B1 Divided dose therapies with vascular damaging activity |
| 06/22/2005 | CN1630635A Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 06/22/2005 | CN1630531A Composition comprising immunogenic microparticles |
| 06/16/2005 | WO2005004989A3 Film comprising therapeutic agents |
| 06/16/2005 | US20050131347 Apparatus for delivery of therapeutic and/or diagnostic agents |
| 06/16/2005 | US20050131237 Indole derivatives |
| 06/15/2005 | EP1541170A1 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 06/15/2005 | EP1248785B1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 06/15/2005 | CN1205964C Medicament for curing colpitismycotica and trichomonal vaginitis and its preparation method |
| 06/15/2005 | CN1205937C Phosphatidic acid-comprising compositions |
| 06/14/2005 | US6906088 Taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions; anticarcinogenic agent |
| 06/14/2005 | US6906048 N-acetylcolchinol-O-phosphate combination therapies with vascular damaging activity |
| 06/14/2005 | US6906044 Regeneration of articular cartilage damaged by grade I and II osteoarthritis by means of the intraarticular application of a mixture of sodium hyaluronate and chondroitin sulfate in a gel vehicle |
| 06/09/2005 | WO2005000403A3 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof |
| 06/09/2005 | US20050124628 Quinoline and aza indole compounds having pharmacological activity, for example, 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; use in the treatment of CNS and other disorders |
| 06/09/2005 | US20050123541 Anti-TNF antibodies, compositions, methods and uses |
| 06/08/2005 | EP1537873A1 The pharmaceutical formulation of traditional chinese medicine for abstinence of drug and preparation method and use thereof |
| 06/08/2005 | EP1001797B1 Soya extract, process for its preparation and pharmaceutical composition |
| 06/08/2005 | CN1625565A Antibodies to non-functional P2X7 receptor, diagnosis and treatment of cancers and other conditions |
| 06/08/2005 | CN1625411A Combination of a NSAID and a PDE-4 inhibitor |
| 06/08/2005 | CN1625392A Composition for inhalation |
| 06/08/2005 | CN1205205C Sodium-hydrogen exchanger type 1 inhibitor crystals |
| 06/07/2005 | US6902744 Exendin agonist formulations and methods of administration thereof |
| 06/02/2005 | US20050119611 Apparatus and method for delivery of therapeutic and/or diagnostic agents |
| 06/02/2005 | US20050119486 Diamine derivatives |
| 06/02/2005 | US20050119316 Semicarbazide derivatives and the use thereof as antithrombotics |
| 06/02/2005 | US20050118200 Two or more inactivated or attenuated Mycoplasma bovis biotypes, inactivated Mycoplasma alkalescens, an adjuvant and excipient; vaccinating cows; no undesirable side effects and protect against M. bovis related disease, such as contagious mastitis, respiratory pneumonia |
| 06/01/2005 | CN1204138C Pyrazolo [4, 3-d] pyrimidine derivs. |
| 05/26/2005 | US20050113565 Pegylated factor VII glycoforms |
| 05/25/2005 | EP1532122A1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 05/25/2005 | CN1620438A 5, 6-diaryl-pyrazine-2-amide derivatives as CBI antagonists |
| 05/25/2005 | CN1620291A 3-(imidazolyl)-2-alkoxypropanoic acids as TAFIA inhibitors |